CellsBin
Rare-Cell Intelligence platform for precision medicine and cell therapy monitoring
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
CellsBin is a Branford, Connecticut biotechnology company pioneering Rare-Cell Biology. Its Rare-Cell Intelligence Platform combines advanced microfluidics, multimodal imaging, single-cell analysis, and AI to detect, characterize, and monitor extremely rare cells. Initial applications focus on cell and gene therapy monitoring and hematologic cancers. CellsBin closed a Series A led by 108 BioCapital to accelerate commercialization, partnerships, and product development.
- Website
- cellsbin.com
- Stage
- series-a
- Location
- Branford, Connecticut, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Polaris — Rare-cell detection and profiling platform for precision medicine